Tony, Yen-Huei Tarn, M.S., Ph.D.President, TaSPOR

Introduction of Taiwan Society for Pharmacoeconomics

and Outcomes Research (TaSPOR)

ISPOR 2ND ASIA-PACIFIC CONFERENCEShanghai Worldfield Convention Hotel

Shanghai, China • 5-7 March 2006

Taipei 101 Building, 40 second to the top

About TaSPOR A non-profit organization in Taiwan, established o

n 18th Jan. 2003. Established with goals to ensure pharmacoeconom

ics and outcomes research are conducted adequately in Taiwan and medical resources are fairly and efficiently distributed.

Became ISPOR Taiwan Chapter on 27th Jan. 2005. Current President: Dr. Tony, Yen-Huei Tarn (Director General, Department of Pharmacy, Taipei City Hospital, Taipei, Taiwan )

Missions of TaSPOR To provide an arena for academic activities on Pharma

coeconomics and Outcomes Research. To facilitate communications among academia, phar. in

dustry and government, and to advocate the importance and value of Pharmacoeconomics and Outcomes Research.

As an intellectual tank on public issues regarding Pharmacoeconomics and Outcomes Research.

To host domestic and international conferences on Pharmacoeconomics and Outcomes Research to encourage the growth in the field.

To provide job seeking opportunities for researchers in Pharmacoeconomics and Outcomes Research.

Organization of TaSPOR

PresidentPresident

Secretary GeneralSecretary GeneralBoard of Directors

19 personsBoard of Directors

19 persons

Academic Affairs Committee

Academic Affairs Committee

Publications Committee

Publications Committee

Public RelationCommittee

Public RelationCommittee

SecretarySecretary Education Promotion Committee

Education Promotion Committee

Full time: one personOthers: part time

Main Tasks of Committees

Academic Affairs Committee To plan and conduct research activities and conferen

ces To edit the specialized teaching material

Publications Committee To issue publications and newsletters To maintain and analyze member information To construct and maintain TaSPOR web site

Main Tasks of Committees

Public Relation CommitteeTo expand domestic and international communicationsTo solicit financial supportsTo recruit and enhance relationships among members

Education Promotion CommitteeTo promote C/E analysis of health care servicesTo plan and execute education activities to members

and general publics

Finance of TaSPOR

Fee for first enter: US $16 for individual members, US$160 for group members and US$8 for student members

Annual membership fee: US$32 for individual members, US$320 for group members, US$16 for student members and US$320 for permanent individual membership fee

Research grant Donations: Pharmaceutical industry Training courses: Pharmaco-Economics Workshop Other revenues: Supports from Department of Health for annual meeting

Annual Budget (2005)

Amount (US$)

Personnel Expense 2,344

Office Expense 313

Operating Expense 7,969

Projects Management Expense 25,000

Total Amount 35,626

Annual Budget (2006)

Amount (US$)

Personnel Expense 2,406

Office Expense 594

Operating Expense 8,996

Projects Management Expense 12,500

Total Amount 24,496

Members from :At creation(persons; %)

2004(persons; %)

2005(persons; %)

Academia 17 ; 26 20 ; 13 21 ; 10

Physician 7 ; 10 14 ; 9 17 ; 8

Pharmacist 6 ; 9 27 ; 18 40 ; 18

Government Officer 2 ; 3 4 ; 3 7 ; 3

Pharmaceutical Industry

24 ; 36 61 ; 41 96 ; 44

CRO Company 6 ; 9 10 ; 7 12 ; 6

Student 4 ; 6 9 ; 6 17 ; 8

Others 0 3 ; 2 10 ; 4

Grand Total 66 148 220

Membership Work Enviroment

Student17; 8%

Govt.7; 3%

Others10; 4%

Physician17; 8%

Pharmacist 40; 18%

Pharmaceutical Industry96; 44%

Academia21; 10%

CRO Company12; 6%

TaSPOR Member Profile (Current,

2006)

N ＝ 220

(persons; %)

Membership Degrees

MS91; 41 %

BS86; 39 %

College3; 1 %Ph.D.

40; 18 %

TaSPOR Member Profile (Current, 2006)

N ＝ 220 (persons; %)

Conferences and Events (2004)5th Jan. 1.Board Meeting (Ⅰ)

2.Start translating the Economics Evaluation Professional Terms to Chinese

5th Feb. Conference ： Outcomes Measurement-- Introduction and Practice of Quality of Life (QALY)

15th Apr. Board Meeting (Ⅱ)

17th May Conference ： Outcomes Research-- Multivariate Modeling

21st Jul. Board Meeting (Ⅲ)

20th Oct. Conference ： A Practical Look at Patient Reported Outcomes for Clinical Research

15th Nov. Board Meeting (Ⅳ)

16th Dec. Conference ： 1.International Practices in Assessing Health Care Technologies

2.Principles of Priority Setting in the 2nd Generation of National Health Insurance in Taiwan

Conferences and Events (2005)22st Jan. TASPOR 2004 Annual Meeting and Conference & Election of the Second Term of

Board Members (83 persons)

24st Feb. Board Meeting ( ) Ⅰ

21st Mar.

Board Meeting ( )Ⅱ

15th Apr.

1.Complete set up of TaSPOR Web Site

2.First issue of Newsletter: 2005, Spring

28st May 1.Conference: Study Methodology of Pharmaco-Economics (51 persons)

2.Board Meeting (Ⅲ) and Dinner Conversation with Gordon Liu (ISPOR Asia Consortium Executive Committee Chair)

30st Jun. 8 series of Pharmaco-Economics Workshop: PE Training Series for Drug Company (32 persons)

8th Jul. Publication Newsletter: 2005, Summer Issue

19th Jul. Visiting Minister of Health to Discuss the Issues of HTA and Pharmaco-Economics Guideline

21st Sep. Board Meeting (IV)

10st Dec.

1.Forum on “Purchasing the Greatest Healthy Value”: Inviting People from Government, Scholar, and Industry (34 persons)

2.Conference: Overview of the Commonest Problems Encountered in Economic Evaluation of Experience from Australia (50 persons)

Works Done in 2005

Complete the translation of Economics Evaluation Professional Terms to Chinese – put on website

Translated 2004 French Guidelines for the Economic Evaluation of Health Care Technologies to Chinese

Research Project: the construction of a PE model for the strategy development of the pharmaceutical industry in Taiwan -- an analysis of ACEI and CCB for the antihypertensive management

ISPOR 2nd Asia-Pacific Conference

3 oral presentations 13 posters

Medline search for publications from Taiwan using keywords: pharmacoeconomic or cost

New Goals in 2006

Guidelines for Methodological Standards of Economic Evaluation of Pharmaceuticals

Guidelines for Submission of Dossier for the Drug Pricing and Reimbursement

Guidelines for Conducting Budget Impact Analysis Guidelines for Preparation of Economic Evaluation

Report Guidelines for Evaluation of PE Reports Guidelines for Evaluation of PE Literatures

Draft

Conference ( 16th Dec. 2004 )

Lieven Annemans

Dinner Conversation with Gordon Liu( 28th May 2005 )

Gordon Liu

Visiting Minister of Department of Health( 19th Jul. 2005 )

Forum on Purchasing the Greatest Healthy Value( 21th Jul. 2005 )

Conference ( 10st Dec. 2005 )

Shu-Chuen Li

Contact TaSPOR

Office Address:TaSPOR, No.145 Zhengzhou Rd., Datong District, Taipei City 10341, Taiwan, R.O.C.

Tel: 886-2-2552-3234 ext. 3081Fax: 886-2-2559-8643

Email: info@taspor.org  Tony Tarn at A1705@tpech.gov.tw